Total Returns (Price + Dividend) 
Chemkart India for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Is Chemkart India overvalued or undervalued?
As of 13 November 2025, Chemkart India has moved from an expensive to a very attractive valuation grade. The company is currently undervalued, as indicated by its PE ratio of 9.82, EV to EBIT of 6.24, and EV to EBITDA of 6.13, which are significantly lower than many peers in the industry. For instance, Elitecon International is classified as very expensive with a PE ratio of 320.89, while PTC India, which is also very attractive, has a PE ratio of 7.67. Chemkart India's strong return on capital employed (ROCE) at 40.41% and return on equity (ROE) at 20.46% further support its undervaluation. Despite recent stock performance lagging behind the Sensex, with a 1-week return of -7.21% compared to the Sensex's 1.40%, the company's fundamentals suggest significant upside potential. Overall, Chemkart India presents a compelling investment opportunity given its attractive valuation metrics relative to its peers....
Read MoreIs Chemkart India overvalued or undervalued?
As of 12 November 2025, Chemkart India has moved from a grade of does not qualify to expensive, indicating a significant shift in its valuation outlook. The company is currently considered overvalued. Key ratios include a PE ratio of 9.68, an EV to EBIT of 7.84, and an ROCE of 47.81%. In comparison to its peers, Chemkart India's PE ratio is notably lower than that of Elitecon International, which stands at 329.04, and much higher than PTC India, which is at 7.7, indicating a relative overvaluation. The recent stock performance shows a decline of 8.35% over the past week, contrasting with a modest gain of 1.21% in the Sensex, further supporting the view that Chemkart India is currently overvalued in the market....
Read More Announcements 
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16-Dec-2025 | Source : BSECopy of Press Release Issued by the Company
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Dec-2025 | Source : BSEIntimation for Analyst/Investors Meet.
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015
15-Dec-2025 | Source : BSEPursuant to regulation 30 read with Schedule III of the SEBI (LODR) Regulations 2015 we want to inform you that the Directorate of Revenue Intelligence (DRI) Mumbai Zonal Unit has issued an arrest memo dated 11th December 2025 in respect of Mr. Ankit Mehta Chairman and Managing Director of Chemkart India Limited in connection with an investigation relating to import transactions of the company under the Customs Act 1962.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 4 FIIs (0.95%)
Parul Shailesh Mehta (36.66%)
Aarth Aif Growth Fund (1.64%)
12.3%
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 14.51% vs -20.31% in Mar 2025
Growth in half year ended Sep 2025 is 14.04% vs -43.09% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






